Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.92
-0.13 (-1.61%)
At close: May 22, 2026, 4:00 PM EDT
8.06
+0.14 (1.77%)
After-hours: May 22, 2026, 7:21 PM EDT
Seres Therapeutics Employees
Seres Therapeutics had 66 employees as of December 31, 2025. The number of employees decreased by 37 or -35.92% compared to the previous year.
Employees
66
Change (1Y)
-37
Growth (1Y)
-35.92%
Revenue / Employee
$17,379
Profits / Employee
-$710,591
Market Cap
76.70M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 66 | -37 | -35.92% |
| Dec 31, 2024 | 103 | -130 | -55.79% |
| Dec 31, 2023 | 233 | -198 | -45.94% |
| Dec 31, 2022 | 431 | 98 | 29.43% |
| Dec 31, 2021 | 333 | 178 | 114.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| MindWalk Holdings | 102 |
| XBiotech | 85 |
| Acrivon Therapeutics | 76 |
| Pliant Therapeutics | 49 |
| eXoZymes | 32 |
| Gain Therapeutics | 21 |
| Atara Biotherapeutics | 14 |
MCRB News
- 4 days ago - Seres Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 11 days ago - Seres Therapeutics to Participate in H.C. Wainwright 4th Annual BioConnect Investor Conference - GlobeNewsWire
- 18 days ago - Seres Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - GlobeNewsWire
- 18 days ago - Seres Therapeutics Earnings release: Q1 2026 - Filings
- 18 days ago - Seres Therapeutics Quarterly report: Q1 2026 - Filings
- 19 days ago - Seres Therapeutics Presents Preclinical Data at Digestive Disease Week (DDW) 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for Inflammatory Bowel Disease - GlobeNewsWire
- 26 days ago - Seres Therapeutics Proxy statement: Proxy filing - Filings
- 26 days ago - Seres Therapeutics Proxy statement: Proxy filing - Filings